Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 08:28 am Sale | 2023-12-31 | 13G | FOREST RD ACQUISITION CORP II FRXB | Farallon Capital Partners, L.P. | 0 0.000% | -400,000 (Position Closed) | Filing History |
| 2024-01-24 10:07 am Sale | 2023-12-31 | 13G | AVROBIO INC AVRO | Farallon Capital Partners, L.P. | 0 0.000% | -259,667 (Position Closed) | Filing History |
| 2024-01-22 09:02 am Purchase | 2024-01-12 | 13G | ELEVATION ONCOLOGY INC ELEV | Farallon Capital Partners, L.P. | 3,100,000 7.300% | 3,100,000 (New Position) | Filing History |
| 2024-01-19 09:05 am Sale | 2023-12-31 | 13G | DISRUPTIVE ACQUISITION CORP I DISA | Farallon Capital Partners, L.P. | 0 0.000% | -1,400,000 (Position Closed) | Filing History |
| 2024-01-18 08:58 am Sale | 2023-12-31 | 13G | ARYA SCIENCES ACQUISITION CORP ARYD | Farallon Capital Partners, L.P. | 200,000 4.800% | -600,000 (-75.00%) | Filing History |
| 2024-01-02 2:25 pm Purchase | 2023-12-20 | 13G | YORK TIMES COCL A NYT | Farallon Capital Partners, L.P. | 9,476,791 5.800% | 9,476,791 (New Position) | Filing History |
| 2023-12-08 4:39 pm Purchase | 2023-12-06 | 13D | CAZOO GROUP LTD OCT 2023 CZOOF | Farallon Capital Partners, L.P. | 714,240 14.600% | 704,240 (+7042.40%) | Filing History |
| 2023-11-09 5:18 pm Purchase | 2023-10-31 | 13G | REVOLUTION MEDICINES INC RVMD | Farallon Capital Partners, L.P. | 6,762,480 6.200% | 6,762,480 (New Position) | Filing History |
| 2023-11-09 5:18 pm Purchase | 2023-10-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Partners, L.P. | 3,961,602 7.100% | 3,961,602 (New Position) | Filing History |
| 2023-11-07 5:04 pm Unchanged | 2023-11-03 | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners, L.P. | 10,000 2.500% | 0 (Unchanged) | Filing History |
| 2023-10-16 4:45 pm Purchase | 2023-10-04 | 13G | ARAMARK ARMK | Farallon Capital Partners, L.P. | 15,381,069 5.900% | 383,065 (+2.55%) | Filing History |
| 2023-09-22 5:05 pm Unchanged | 2023-09-20 | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners, L.P. | 10,000 2.500% | 0 (Unchanged) | Filing History |
| 2023-09-22 3:20 pm Purchase | 2023-09-13 | 13G | BEAM THERAPEUTICS INC BEAM | Farallon Capital Partners, L.P. | 4,113,469 5.200% | 713,548 (+20.99%) | Filing History |
| 2023-08-11 5:17 pm Purchase | 2023-08-02 | 13D | CHINOOK THERAPEUTICS INC KDNY | Farallon Capital Partners, L.P. | 7,110,000 9.900% | 7,110,000 (New Position) | Filing History |
| 2023-08-10 3:57 pm Purchase | 2023-07-31 | 13G | FORTE BIOSCIENCES FBRX | Farallon Capital Partners, L.P. | 151,505 9.900% | 151,505 (New Position) | Filing History |
| 2023-06-16 5:21 pm Unchanged | 2023-06-15 | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners, L.P. | 10,000 2.600% | 0 (Unchanged) | Filing History |
| 2023-06-02 4:59 pm Purchase | 2023-05-31 | 13D | EXELIXIS INC EXEL | Farallon Capital Partners, L.P. | 25,860,000 7.900% | 2,394,000 (+10.20%) | Filing History |
| 2023-05-16 5:25 pm Unchanged | 2023-05-12 | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners, L.P. | 10,000 2.600% | 0 (Unchanged) | Filing History |
| 2023-04-27 5:28 pm Unchanged | 2023-04-25 | 13D | CAZOO GROUP LTD CZOO | Farallon Capital Partners, L.P. | 10,000 2.600% | 0 (Unchanged) | Filing History |
| 2023-04-06 8:54 pm Unchanged | 2023-04-05 | 13D | EXELIXIS INC EXEL | Farallon Capital Partners, L.P. | 23,466,000 7.200% | 0 (Unchanged) | Filing History |